Arbutus Biopharma Corporation (ABUS) Event June 06, 2022, 11:31 UTC 12 1 comments (85% Positive) Arbutus Biopharma Corporation (ABUS) Provides Update on patients for a Phase 2a clinical trial Comment Full text
AstraZeneca (AZN) Event June 06, 2022, 11:23 UTC 11 1 comments (10% Negative) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT) Event June 06, 2022, 10:30 UTC 12 1 comments (10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Announces Delay in trial Trials for liver fibrosis due to NASH Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
BioNTech SE (BNTX) Event June 06, 2022, 10:10 UTC 9 1 comments (10% Negative) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Comment Full text
Legend Biotech (LEGN) Event June 06, 2022, 10:00 UTC 9 1 comments (10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K) Comment Full text
Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) Event June 03, 2022, 21:15 UTC 10 1 comments (99% Neutral) Turning Point Therapeutics, Inc. (TPTX) Announces Business Combination Comment Full text
Aclaris Therapeutics Inc (ACRS) Event June 03, 2022, 21:15 UTC 10 1 comments (99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces Regulatory Update Comment Full text
Harpoon Therapeutics Inc (was acquisited by Merck (NYSE:MRK) on 11/03/2024) (HARP) Event June 03, 2022, 21:05 UTC 10 1 comments (70% Positive) Harpoon Therapeutics, Inc. (HARP) Announces Clinical Development Update Comment Full text
Selecta Biosciences Inc (SELB) Event June 03, 2022, 20:30 UTC 12 1 comments (99% Neutral) SELECTA BIOSCIENCES, INC. (SELB) Files Form 8-K Comment Full text
Sarepta Therapeutics Inc (SRPT) Event June 03, 2022, 20:20 UTC 11 1 comments (99% Neutral) Sarepta Therapeutics, Inc. (SRPT) Announces New Board Appointment Comment Full text